Categories: New Launches

Vijyoti and TEM International enter exclusive alliance to introduce Patient Blood Management enabling technologies in India

New Delhi, April 05, 2016: Vijyoti, India’s leading corporate social enterprise with specialization in innovation management in the pharma and education sector has partnered with TEM International, a leading German medical technology company that is redefining bleeding control through its proprietary ROTEM® (Rotational Thromboelastometry) point-of-care diagnostic equipment to introduce cutting edge solutions for patient blood management in India.

ROTEM – The Optimal Haemostasis Analyser is the first choice solution for doctors globally in detecting, managing and monitoring haemostasis in cardiac surgery, liver transplant. obsetrics and trauma patients. The analyzer provides precise results within 5-10 minutes, whereas standard laboratory testing takes up to 40-60 minutes. The technology allows for targeted therapy to be provided at the point-of-care (POC).

Speaking on the occasion of India’s first National Symposium on Innovations in Bleeding Management, Dr. Klaus Goerlinger, Senior Consultant for Anaesthesiology, Intensive Care and Emergency Medicine, University Duisburg-Essen, Germany, said:. “Bleeding and blood transfusion have been shown to be independent risk factors for increased morbidity and mortality. Our collaboration with Vijyoti will help introduce ROTEM as an integral technology to patient blood management in India, one that will allow for point-of-care decisions for blood transfusion to be the last resort and not the first option to manage bleeding.”

Speaking on the occasion Mr. Vijay Pande, Managing Director, Vijyoti, said, “Despite being a country with a population of 1.2 billion, India faces a blood shortage of three million units annually. Patient blood management demands a change in the mindset towards bleeding management. Entering into the healthcare segment through our alliance with TEM International, Vijyoti is immensely honoured to introduce ROTEM to India and promote blood conservation with benefit to the patient, the blood banks and hospitals by enabling efficient and economical use of this increasingly scarce, expensive resource.”

ROTEM conducts four tests simultaneously – EXTEM, INTEM, FIBTEM and APTEM/HEPTEM. The easy-to-use portable device comes with a powerful intuitive software package and a sophisticated data handling system. The database stores all results and can be easily exported into MS Excel or other software for further processing.

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

World Diabetes Day Survey: Diabetologists and Endocrinologists demand for AI-Based Training and Upskilling in Diabetes Care

 A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…

1 day ago

Doctors warn diabetes patients about risk of smoking

People who smoke are also at much higher risk of developing diabetes compared to non-smokers…

3 days ago

CPHI & PMEC India Expo: Encouraging affordable solutions in India’s march towards a $130 Billion Pharma Market by 2030

17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…

3 days ago

Sringeri Sharada Equitas Hospital Revolutionizing Cancer Care with the Launch of Low-cost, High Quality Radiation Therapy

The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…

3 days ago